Testing effectiveness (Phase 2)Study completedNCT00003575
What this trial is testing
Interleukin-12 Following Chemotherapy in Treating Patients With Refractory HIV-Associated Non-Hodgkin's Lymphoma
Who this might be right for
Lymphoma
National Cancer Institute (NCI) 40